Free beta access. 50 free AI tokens each week. Optional top-ups available. See what is included
Open evidence library

Search the archive.

Current and older evidence is free during beta. Sign in for unlimited card access and full source downloads.

Matching cards
2023 SDI Affirmative
MSDI – Medicare for All Affirmative › 1AC --- Growth Advantage

Medicare for All also solves job lock and boosts small business creation.

• March 5, 2020 Josh Bivens joined the Economic Policy Institute in 2002 and is currently EPI’s director of research. His primary areas of research include macroeconomics, social insurance, and globalization. Fundamental health reform like ‘Medicare for All’ would help the labor marketJob loss claims are misleading, and substantial boosts to job quality are often overlooked • https://www.epi.org/publication/medicare-for-all-would-help-the-labor-market/

Medicare for All could decrease inefficient “job lock” and boost small business creation and voluntary self-employment. Making health insurance universal and delinked from employment widens the range of economic options for workers and leads to better matches between workers’ skills and interests and their jobs. The boost to small business creation and self-employment would be particularly useful, as the United States is a laggard in both relative to advanced economy peers. Substantial evidence indicates that our current system of employer-sponsored insurance (ESI) creates significant “job lock”—a condition in which workers who don’t want to lose their current ESI stay in their current jobs rather than make transitions that would better meet their needs. In a comprehensive review of this literature, Baker (2015) finds: The likely range of a job-lock effect is a reduction in turnover—the rate at which people leave jobs—of 15–25 percent among workers with EPHI [employer-provided health insurance, or ESI]. With normal turnover for prime-age workers (people ages 25–54) in the range of 15–20 percent per year, this job-lock effect implies a reduction in annual turnover of around 4 percentage points among prime-age workers with [employer-provided health insurance, or ESI]. Making employment decisions based on access to ESI rather than on other criteria—such as work–life balance, cash wages, and commuting distance—can lead to employment “matches” that are less productive and that decrease overall worker welfare relative to job choices that are not constrained by the availability of health insurance.

2023 SDI Affirmative
MSDI – Medicare for All Affirmative › 1AC --- Growth Advantage

Both medical debt and dampening wage growth are significant factors in the decline of consumer confidence, which is a leading economic indicator and critical to GDP growth.

Justin Kuepper Updated on November 14, 2021 Consumer Confidence and Its Impact on the Markets https://www.thebalancemoney.com/consumer-confidence-and-its-impact-on-the-markets-1978947

There is little question that fuels most developed service-based economies, including the U.S., where it represents about 70% of gross domestic product (GDP).1 While measuring this spending is rather straightforward, predicting future trends can be very difficult, given the fickle and scattered nature of consumers on an aggregate basis. This article will look at what consumer confidence is, and how investors can use the indexed information to make better decisions. How Is Consumer Confidence Measured? Economists solved the problem of measuring by developing what is now known as the (CCI). By questioning a statistically significant number of people residing within a given country using surveys, they aim to measure the degree of optimism that consumers feel about the overall state of a country's economy and their financial situation.2 When consumers are confident in their futures, they tend to spend money and drive economic growth higher. When consumers aren't confident, they tend to save rather than spend, which restricts economic growth. Therefore, international investors pay close attention to the information gathered in these surveys since it can serve as a great leading indicator for the overall economy.

2023 SDI Affirmative
MSDI – Medicare for All Affirmative › 1AC --- Growth Advantage

High health care costs are also dampening wage growth

Maximilian Pany, Jeannie Fuglesten Biniek and Tricia Neuman Published: May 31, 2022 Price Regulation, Global Budgets, and Spending Targets: A Road Map to Reduce Health Care Spending, and Improve Affordability https://www.kff.org/health-costs/report/price-regulation-global-budgets-and-spending-targets-a-road-map-to-reduce-health-care-spending-and-improve-affordability/

The U.S. spends more on health care than any other country, and U.S. health care spending has risen more rapidly than the economy as a whole over the last few decades. High and rising health care spending drives increasing premiums and out-of-pocket costs for workers and their families and for employers who fund a large share of that coverage. Between 2010 and 2018, spending per person with private insurance grew considerably faster than for people covered by Medicare, increasing at an average annual rate of 3.8% compared to a rate of 1.7%. Nationwide, 173 million people under age 65 have private health insurance, either from an employer plan (155 million) or the non-group market (18 million), accounting for more than $1 trillion in health care spending in 2019. Health care expenses for employers are consuming a growing share of total employee compensation and dampening wage growth.11 Rising health care spending also contributes to higher government spending through the tax exclusion for employer-sponsored health insurance, health benefits for public employees, and direct subsidies of non-group plans under the ACA.

2023 SDI Affirmative
MSDI – Medicare for All Affirmative › 1AC --- Growth Advantage

The outlook on affordability is worsening and medical debt is skyrocketing

Radley, et.al., , , , June 22 2023

Health insurance coverage rates reached record highs in 2021, but declines loom on the horizon, and concerns with the affordability of health care are growing. The number and percentage of Americans lacking health insurance has fallen to historic lows. That’s because of temporary policies during the pandemic aimed at helping people get covered and stay covered, as well as recent decisions by several states to expand Medicaid eligibility under the Affordable Care Act (ACA). Still, many people in the United States remain uninsured or inadequately covered. As pandemic-era policies expire and health care costs continue to climb, the outlook is likely to worsen. The national adult uninsured rate declined during the first two years of the pandemic, from nearly 13 percent in 2019 to 12.1 percent in 2021 (see ). Across the nation, uninsured rates declined in all but seven states, falling even in most states that had not expanded their Medicaid programs. This nationwide improvement in coverage was attributable to record enrollment in Medicaid (93 million by 2023) and in the ACA insurance marketplaces (16.4 million by 2023). Four policy changes accounted for these coverage gains: The 2020 federal requirement that states keep Medicaid beneficiaries continuously enrolled through the end of the public health emergency, in exchange for enhanced federal matching funds for state Medicaid programs. The decision by seven additional states between 2019 and 2021 — Idaho, Maine, Missouri, Nebraska, Oklahoma, Utah, and Virginia — to expand Medicaid eligibility. More generous marketplace premium subsidies that were put in place in 2021 and extended through 2025 under the Inflation Reduction Act. Increased federal funding for ACA marketplace outreach and enrollment. The substantial gains achieved through Medicaid’s continuous coverage requirement may prove ephemeral, however. The requirement ended in April 2023, leaving states with the complex and difficult task of determining whether people enrolled are still eligible. An estimated 15 million people may lose Medicaid coverage over the next year, either from changes in eligibility or through administrative error. Of those, the Congressional Budget Office projects that 6.2 million will become uninsured. Among those most at risk of losing coverage are people who have Medicaid because they were pregnant but are now out of the postpartum period, and young adults who aged out of Medicaid and the Children’s Health Insurance Program (CHIP). This will particularly affect those who live in states that have not expanded Medicaid or have not yet extended postpartum coverage as allowed during the pandemic. Coverage losses could be exacerbated by the burdensome process of redetermining eligibility for so many people, since state Medicaid agencies are likely to fall behind in enrolling new applicants as a result. In some states, medical debt is a crisis for the insured and uninsured alike. Despite the nation’s substantial gains in health insurance coverage, many Americans are struggling to pay off medical debt. There are two key reasons: 1.) millions remain uninsured, and 2.) many people with coverage are underinsured, meaning they still face high costs when they get health care. In 2022, the Commonwealth Fund found that nearly a quarter of adults had coverage all year but were still underinsured. Of those, 39 percent were paying off medical debt, slightly higher than the share of uninsured people with medical debt. In 2021, there was an estimated $88 billion of medical debt on consumer credit records, accounting for 58 percent of all debt-collection entries on credit reports—by far the largest single source of debt. This estimate is an undercount of U.S. households’ medical debt since it does not include debt people owe directly to hospitals and other providers. Of the estimated 230 million people in the U.S. who had credit reports in February 2022, nearly 13 percent had medical debt in collections. The share of people with medical debt in collections varied significantly across the country from 2.4% in Minnesota to 24 percent in West Virginia. Southern states had the highest rates of medical debt in collections; the region not only has some of the highest state uninsured rates in the country, but out-of-pocket cost exposure in commercial health plans is also among the highest relative to people’s incomes.

2023 SDI Affirmative
MSDI – Medicare for All Affirmative › 1AC --- Growth Advantage

The effect on economy is significant – a 1 percent increase in coverage translates into 0.3 percent growth by increasing productivity and labor supply.

Malloy et al 16 [Liam Malloy, University of Rhode Island. Shanna Pearson-Merkowitz, University of Rhode Island. Irwin Morris, University of Maryland.] “State-Sponsored Health Insurance and State Economic and Employment Growth” Politics and Policy Volume 44, Issue 5, October 2016, Pages 945–975 (doi.org/10.1111/polp.12176)

Economic Growth and Health Insurance Rates in the U.S. States Table 3 presents the GMM regression results for the U.S. state panel dataset without spending. The main finding is that health insurance coverage for the working age population (18-65 year olds) has a positive effect on economic growth. Column (i) shows that a 1 percentage point increase in coverage for the working age population is associated with an increase of 0.306 percentage points of contemporaneous annual growth. Column (ii) breaks out coverage by private versus public health-care plans and we can see that the positive effect is mainly due to public coverage (the coefficient on private coverage is positive but insignificant and much smaller). In column (iii) we break this out further to distinguish between Medicaid, Medicare, and Military coverage. They are all significant (at least at the 10 percent level) and of similar size, although military coverage appears to have the largest effect. This is not surprising given the federal spending that comes along with having a large military population in the state. Coverage for those under 18, who by and large are not in the workforce, is not significant and the economic effect is quite small in all three of these regressions. Keep in mind that these regressions only measure the contemporaneous effect of health insurance coverage on economic growth rather than the long-run effect that might be present in covering children who may grow up to be healthier and more productive workers. Unfortunately, our dataset is not long enough to capture these effects. Our dataset also allows us to look at the effect of health-care spending on economic growth. We have the data broken down by type (private spending, Medicare spending, and Medicaid spending) and as a percent of the states’ GDP and on a per-enrollee basis.20 Increased spending on health care may drive economic growth, especially if health care is a driver of productivity growth. Conversely, higher health-care spending will decrease spending in other industries which may decrease growth if those other industries are more productive. Our results, presented in Table 4, show that personal health-care spending, whether measured as a percent of GDP (column (i)) or per capita (column (ii)) has a significant negative effect on growth. This implies that private health-care spending, which was growing much faster than GDP in our sample, is a significant drag on growth. Government health-care spending, on the other hand, has a positive effect on growth, especially Medicaid spending, although this is not always statistically significant. Our regressions in Table 4 include health insurance coverage variables. These become insignificant in columns (i) and (ii) where private and government coverage are lumped together, but are (weakly) significant when we break out coverage by private versus public in columns (iii) and (iv). Once again it is government coverage for the working age population that has a positive effect on contemporaneous economic growth. In column (v), which includes spending both as a percent of GDP and per capita (or per-enrollee) costs, total Medicaid spending as a percent of GDP continues to have a positive effect on growth while personal health-care spending as a percent of GDP has a significantly negative effect. The per capita and per-enrollee variables all have negative coefficients, but are not statistically significant.21 Another test that may help distinguish between the relative impacts of potential labor supply and health-care innovation on growth is to use total employment growth22 as our dependent variable as opposed to economic growth. Table 5 repeats the regressions of Table 3 with employment growth as the dependent variable and health insurance coverage as the main independent variables of interest. These results mirror the earlier results with total coverage of the working age population, in column (i), increasing employment growth (while controlling for the employment to population ratio). Column (ii) shows that this is due to government coverage as opposed to private health insurance coverage, and column (iii) shows the effects are due equally to Medicaid and Medicare coverage. These results strongly imply that providing health coverage to this vulnerable population (mainly the poor, the disabled, and the working elderly) increases their labor supply significantly.

2023 SDI Affirmative
MSDI – Medicare for All Affirmative › 1AC --- Growth Advantage

A consensus of the best studies proves Medicare for All would result in significant health care costs savings – especially administrative costs.

Joanne Finnegan Jan 15, 2020 02:46pm New study says 'Medicare for All' will save the U.S. money with lower healthcare costs https://www.fiercehealthcare.com/practices/new-study-says-medicare-for-all-will-save-u-s-money-lower-healthcare-costs

As the debate over how to lower healthcare costs in the U.S. continues, including whether "Medicare for All" is the answer, a new study finds a consensus that a single-payer system would result in savings. A single-payer healthcare system would save money over time—and likely even during the first year—according to a review of 22 analyses of both national and state single-payer proposals made over the past 30 years, according to a study published Wednesday in PLOS Medicine. The study is the first of its kind that reviewed analyses of single-payer proposals and provides strong evidence that Medicare for All would be financially affordable for the U.S., said the study’s first author Christopher Cai, a third-year medical student at the University of California, San Francisco (UCSF), in an interview with FierceHealthcare. To study the consequences of what would happen if the U.S. adopted a single-payer system, researchers from the University of California in San Francisco, Los Angeles and Berkeley examined 22 economic analyses by government, business and academic organizations of national and state-level single-payer plans, including proposals made in Massachusetts, California, Maryland, Vermont, Minnesota, Pennsylvania, New York and Oregon. These analyses were used by policymakers to evaluate the proposals, estimating savings the plans would create through simplified billing and lower drug costs while also taking into account increases in health spending that would arise as newly insured people sought healthcare, the study said. Nineteen of the studies showed the U.S. would save money in the first year of adoption, averaging 3.5% of total healthcare spending, and all of the studies showed healthcare savings in the long term. The greatest source of savings comes from reduced administrative costs, with further savings from lower drug costs, the study found. The models were created by analysts from different political perspectives, and they provided a range of cost estimates in the first year of operation, from 7% higher to 15% lower. In the long term, savings from simplified payment administration and reductions in drug prices and other efficiencies ranged from 3% to 27%, with the largest savings found in plans that lowered drug costs, the study said.

2023 SDI Affirmative
MSDI – Medicare for All Affirmative › 1AC --- Growth Advantage

The drain of health care spending getting worse – national expenditures could grow at a rate of 7.1% in the next five years.

Addie Fleron and The gathering storm: The uncertain future of US healthcare September 16, 2022 | Article https://www.mckinsey.com/industries/healthcare/our-insights/the-gathering-storm-the-uncertain-future-of-us-healthcare

The arrival of the COVID-19 pandemic marked the end of a decade of relative calm in US healthcare. From 2010 to 2019, real spending on healthcare rose only 0.3 percentage points above growth in real GDP. This compares with a 3.0 percentage-point differential in the decade before the enactment of the Affordable Care Act. Historically, periods of acceleration in healthcare costs well above the growth of the economy have resulted in fiscal interventions by the government (Exhibit 1). Moreover, economic recessions in these periods have led to broader healthcare reforms (Exhibit 2). As inflation persists at the highest levels since the 1970s, the economy has experienced two successive quarters of negative GDP growth and heightened risk of a recession. As a result, the potential for discontinuous change in healthcare has increased. Our analysis finds that national health expenditure could grow at a rate of 7.1 percent over the next five years from 2022 to 2027, compared with an expected economic growth rate of 4.7 percent. In aggregate, this would equate to healthcare expenditure growth in excess of economic growth of 2.4 percentage points. Health expenditure growth could exceed economic growth by up to 5.9 percentage points in 2023, creating enormous affordability pressure. The potential for healthcare expenditure growth to exceed economic growth so significantly in the shorter term is driven by a combination of current high inflation, a persistent clinical staff shortage, and lower economic growth in 2023 (Exhibit 3).

2023 SDI Affirmative
MSDI – Medicare for All Affirmative › 1AC --- Growth Advantage

The current trajectory of health care spending is unsustainable. The health care sector is the most consequential part of the U.S. economy and a crash is coming.

Ryan Nunn, Assistant Vice President for Applied Research in Community Development (Federal Reserve Bank of Minneapolis) and Jana Parsons, former Research Analyst at the Hamilton Project March 10 2020 A dozen facts about the economics of the US health-care system https://www.brookings.edu/research/a-dozen-facts-about-the-economics-of-the-u-s-health-care-system/

The health-care sector is in many ways the most consequential part of the United States economy. It is a fundamental part of people’s lives, supporting their health and well-being. Moreover, it matters because of its economic size and budgetary implications. The health-care sector now employs 11 percent of American workers (Bureau of Labor Statistics [BLS] 1980–2019b and authors’ calculations) and accounts for 24 percent of government spending (Centers for Medicare & Medicaid Services [CMS] 1987–2018; Bureau of Economic Analysis 1987–2018; authors’ calculations).[1] Health insurance is the largest component (26 percent) of nonwage compensation (BLS 2019b) and health care is one of the largest categories of consumer spending (8.1 percent of consumer expenditures; BLS 2019a). A well-functioning health-care sector is therefore a prerequisite for a well-functioning economy. Unfortunately, the problems with U.S. health care are substantial. The United States spends more than other countries without obtaining better health outcomes (Papanicolas, Woskie, and Jha 2018). Health care is growing as a share of the economy and government budgets in ways that appear unsustainable (CMS 1960–2018; Organisation for Economic Co-operation and Development [OECD] 2015). This growth has slowed at times; health spending as a share of GDP was roughly flat in much of the 1990s, and growth has also slowed to some extent in recent years. But even if expenditures as a share of GDP plateaued at their current level, they would still represent a massive expenditure of resources. Sixty years ago, health care was 5 percent of the U.S. economy, as can be seen in figure A; at 17.7 percent in 2018, it was more than three times that. This growth represents a range of factors, from new health-care treatments and services to better coverage, higher utilization, and rising prices. Some of these changes are desirable: As a country gets richer, spending a higher share of income on health may be optimal (Hall and Jones 2007).[2] Countries with a higher level of output per capita tend to have a higher level of health expenditures per capita (Sawyer and Cox 2018). In addition, as the population ages, health deteriorates and health-care spending naturally rises. Finally, if productivity advancements are more rapid in tradable goods like agriculture or manufacturing than in services like health care or education, the latter will tend to rise in relative price and as a share of GDP.[3] But some of the increase in health-care costs is undesirable (Cutler 2018). Rent-seeking, monopoly power, and other flaws in health-care markets sometimes result in unnecessary care or in elevated health-care prices. In several of the facts that follow, we describe these factors and how they are shaping health care. Spending by private and public payers have both increased. The United States has a health-care system that largely consists of private providers and private insurance, but as health care has become a larger part of the economy, a higher share of health-care funding has been provided by government (figure B). As of 2018, 34 percent of Americans received their health care via government insurance or direct public provision (Berchick, Barnett, and Upton 2019). As shown in figure C, health care has doubled as a share of total government expenditures in the last three decades, from 11.9 percent in 1990 to 24.1 percent in 2018. This increase comes from the rising shares of the population enrolled in Medicare, Medicaid, state Children’s Health Insurance Programs, and veterans’ health benefits. Policy changes like the introduction of the Medicare prescription drug benefit (Part D) in 2006 and a major expansion of Medicaid eligibility in 2014 played important roles. At the same time, spending on discretionary programs like education and research and development have decreased as a share of GDP (Congressional Budget Office 2020). If health expenditures continue to increase as a share of government spending, the increase will eventually necessitate either tax increases or reduced spending on other important government functions like public safety, infrastructure, research and development, and education. Of course, health costs are also borne by the private sector. Firms and households in the United States spent 10 percent of GDP on health care in 2018. Despite widespread coverage—as of 2018, 91.5 percent of Americans had either private or government health insurance for all or part of the year (Berchick, Barnett, and Upton 2019)—many people still face large and variable out-of-pocket health-care costs. In 2017, more than 1 in 50 Americans who interact with the health-care system have out-of-pocket costs in excess of $5,000, and 1 in 200 have costs over $10,000.[4] At the other end of the distribution, roughly one in seven have no out-of-pocket costs at all in a given year (figure D).[5] The upper end of the distribution of out-of-pocket costs dwarfs the liquid resources of many U.S. households, meaning that many people faced with a negative health shock may also find themselves in financial trouble. Negative health shocks tend to be associated with loss of income, thereby compounding the problem (Garcia-Gómez et al. 2013). Unexpected health costs can generate bankruptcies and ongoing financial hardship (Gross and Notowidigdo 2011).[6]

2023 SDI Affirmative
MSDI – Medicare for All Affirmative › 1AC --- Health Advantage

Bioengineered pandemics are the biggest existential risk – and COVID makes them more likely.

Bryan Walsh 20 The coronavirus pandemic reawakens bioweapon fears, 5-14-2020, https://www.axios.com/coronavirus-pandemic-pathogen-bioweapon-45417c86-52aa-41b1-8a99-44a6e597d3a8.html

The immense human and economic toll of the COVID-19 pandemic only underscores the threat posed by pathogens that could be deliberately engineered and released. Why it matters: New technology like gene editing and DNA synthesis has made the creation of more virulent pathogens easier. Yet security and regulation efforts haven't kept pace with the science. What's happening: Despite some claims by the White House, overwhelming scientific evidence indicates that the novel coronavirus was not accidentally released from a lab or deliberately engineered, but naturally spilled over from an animal source. That doesn't mean the threat from bioweapons isn't dire. Along with AI, engineered pandemics are widely considered the biggest existential risk facing humanity. That's in part because a pathogen could be engineered in a lab for maximum contagiousness and virulence, well beyond what would arise through natural selection. Case in point: a 2018 pandemic simulation put on by the Johns Hopkins Center for Health Security featured a fictional engineered virus called Clade X that combined the contagiousness of the common cold with the virulence of the real-life Nipah virus, which has a mortality rate of 40-75%. The resulting simulated global outbreak killed 150 million people. COVID-19 isn't anywhere near that fatal, but the pandemic has shown the vulnerability of the U.S. and the world to biological threats both natural and manmade. "Potential adversaries are of course seeing the same things we’re seeing," says Richard Pilch of the Middlebury Institute of International Studies. "Anyone looking for a radical leveling approach — whether a state actor like North Korea or a motivated terrorist organization — may be influenced by COVID-19 to consider pursuing a biological weapons capability." Background: Bioweapons were officially banned by the Biological Weapons Convention in 1975, though North Korea is suspected of maintaining an offensive bioweapons program. A particular concern about biowarfare and bioterror, though, is that many of the tools and methods that could be used to create a weaponized virus are largely indistinguishable from those used in the course of legitimate scientific research. This makes biotechnology "dual-use" — and that much more difficult to safely regulate without cutting off research that could be vitally important. While earlier bioweapons fears focused on the possibility that a state or terror group could try to weaponize a known dangerous agent like smallpox — which would require somehow obtaining restricted pathogens — new technology means that someone could obtain the genetic sequence of a germ online and synthesize it in the lab. "If you've been trained in a relevant technical discipline, that means you can make almost any potentially harmful agent that you're aware of," says Kevin Esvelt, a biologist at the MIT Media Lab and a member of the CDC's Biological Agent Containment Working Group. That would include the novel coronavirus that causes COVID-19, which was recently synthesized from its genetic sequence in a study published in Nature. How it works: Currently, synthetic DNA is ordered through commercial suppliers. But while most suppliers screen DNA orders for the sequences of dangerous pathogens, they're not required to — and not all do, which means safety efforts are "incomplete, inaccurate, and insecure," says Esvelt. Screening efforts that look for the genetic sequences of known pathogens also wouldn't necessarily be able to detect when synthetic DNA was being used to make something entirely novel and dangerous. In the near future, desktop DNA synthesizers may be able to generate synthetic DNA in the lab, cutting out the need for commercial suppliers — and potential security screenings. The democratization of biotechnology could unleash a wave of creativity and innovation, just as the democratization of personal computing did. But it also increases the number of people who could potentially make a dangerous engineered virus, whether deliberately or by accident.

2023 SDI Affirmative
MSDI – Medicare for All Affirmative › 1AC --- Health Advantage

Additionally, access to health care is critical to defend against bioterrorism.

Kimberly Ann Petersen The Affordable Care Act: A Prescription for Homeland Security Preparedness? Securities Studies Master’s Thesis at the Naval Postgraduate School, September 2014, https://pdfs.semanticscholar.org/fb9f/ebe8552f121bde33c7127aa7c46bf02493c2.pdf

B. BIOTERRORISM …the healthcare of all persons living in America is bound together: the protection of every American is no stronger than the weakest protection of any American. –Philip Bobbitt48 As Professor Philip Bobbitt argued in his amicus curiae to the Supreme Court in support of the Affordable Care Act,49 health care is one of the bastions of homeland security defense. Detection, treatment, and even prevention of bioterror attacks are all functions of a robust health care system. Without an affordable health care system, accessible to all, homeland security suffers increased vulnerability to attacks utilizing bioweapons such as anthrax, smallpox, Ebola virus, or designer bioweapons. Potential weapons are not limited to distribution via inhalation or aerosolization, our open water supplies and unprotected food networks are vulnerable as well. Advances in biotechnology and the Internet have taken the knowledge needed to synthesize bioweapons out of the hands of a few skilled professionals and put it in the public arena. Full genomic sequences are available on the Internet for the avian flu,50 West Nile virus,51 and countless others. Our own National Center for Biotechnology Information, part of the U.S. Library of Sciences, provides information on its website on how to sequence genomes, map chromosomes and do all sort of molecular biology that once was limited to specially trained researchers.52 Advances in DNA technology, such as polymerase chain reaction (PCR) techniques and recombinant DNA technology, have made gene manipulation commonplace. In the future, an average science student could be the next mass-murderer via designer disease. 1. Bioterror and the Health Care Surveillance System The initial identification of a bioterror attack requires a functional health care surveillance system. Unless the attacker(s) announces the specifics of the attack, or the country’s biosensors are activated by the biological weapon, it is likely we would only become aware of a biological attack via the health care system’s surveillance program. Hospitals, health care providers and clinical laboratories around the U.S. routinely report infectious disease diagnoses and food and water-borne illnesses to the Centers for Disease Control and Prevention (CDC). The CDC manages the Emerging Infections Program (EIP) as part of its Division of Preparedness and Emerging Infections. The EIP is a network of 10 state health departments53 and their collaborators that include local health departments and health care providers, clinical laboratories, academic institutions, and other federal agencies. These institutions gather data on disease outbreaks and foodborne illnesses. The EIP compiles data and analyzes it. Once it spots clusters or identify outbreaks, it communicates and collaborates with state and local health care networks and regulatory agencies such as the Food and Drug Administration (FDA) in an effort to trace the origin of the disease and find appropriate treatments.54 Strength of the health care surveillance system aside, if the sickened do not report for diagnosis and treatment, the entire system is rendered ineffective. And if the sickened merely wait longer to report for treatment because they lack health insurance, they are more likely to have poor health outcomes, which can worsen the overall effect of the outbreak.55 A perfect example would be the anthrax attack of 2001, which occurred only one week after the defining act of terrorism against America. With anthrax infection, early diagnosis and treatment are critical factors in determining whether the victim lives or dies.56 In the 2001 event known as “Amerithrax,”57 22 individuals were infected with the anthrax spores, five of whom died, after a still unconfirmed suspect58 sent the spores through the mail. Anthrax is treatable via antibiotics if correctly diagnosed early enough in the progression of the illness. In order to diagnose the disease, the stricken must present to a health care provider. Decades of research has shown a strong association between health insurance and access to health care.59 In other words, if people have health insurance, they are more likely to go to the doctor when they are ill. Conversely, a lack of health insurance equals worse health outcomes because patients wait longer to seek care and present at a later stage of illness.60 Anthrax is not contagious; a person sickened with anthrax cannot pass the disease to another person. If a bioattack involves a contagious disease, early identification and treatment are even more critical. In such a case we would be vulnerable to the initial infections as well as the ensuing spread. Without accessible health care, the lack of assessment, isolation and quarantine would allow the disease to spread unchecked. An example of how 48 million uninsured Americans create a homeland security gap would be a low-tech suicide attack, such as one where a terrorist self-infects with an Ebola virus. The various Ebola viruses have mortality rates ranging from 34 percent to 90 percent.61 Early detection, reporting, and treatment would be critical to minimizing deaths. By waiting longer to seek treatment, the stricken would continue infecting others and exacerbate the rate of spread, particularly during the incubation period. The results could be devastating. Christopher Chyba and Alex Greninger highlight this danger in their article, “Biotechnology and Bioterrorism: An Unprecedented World,” in which they point out that because most dangerous contagious pathogens (smallpox, plague, SARS) have incubation periods longer than international flight travel times, it is crucial that international disease surveillance and response be improved along with its domestic counterpart.62

2023 SDI Affirmative
MSDI – Medicare for All Affirmative › 1AC --- Health Advantage

Breaking the chain of a pandemic in the US prevents extinction: the density of global connections makes the plan necessary because of unique risk – no burnout

Yaneer Bar-Yam 16, physicist and complex systems scientist, Founding President of the New England Complex Systems Institute, Ph.D., S.B., physics, Massachusetts Institute of Technology, “Transition to extinction: Pandemics in a connected world,” NECSI, 7-3-2016,

[ FIGURE 1 OMITTED ] The video (Figure 1) shows a simple model of hosts and pathogens we have used to study evolutionary dynamics. In the animation, the green are hosts and red are pathogens. As pathogens infect hosts, they spread across the system. If you look closely, you will see that the red changes tint from time to time — that is the natural mutation of pathogens to become more or less aggressive. Watch as one of the more aggressive—brighter red — strains rapidly expands. After a time it goes extinct leaving a black region. Why does it go extinct? The answer is that it spreads so rapidly that it kills the hosts around it. Without new hosts to infect it then dies out itself. That the rapidly spreading pathogens die out has important implications for evolutionary research which we have talked about elsewhere [1–7]. In the research I want to discuss here, what we were interested in is the effect of adding long range transportation [8]. This includes natural means of dispersal as well as unintentional dispersal by humans, like adding airplane routes, which is being done by real world airlines (Figure 2). [ FIGURE 2 OMITTED ] When we introduce long range transportation into the model, the success of more aggressive strains changes. They can use the long range transportation to find new hosts and escape local extinction. Figure 3 shows that the more transportation routes introduced into the model, the more higher aggressive pathogens are able to survive and spread. [ FIGURE 3 OMITTED ] As we add more long range transportation, there is a critical point at which pathogens become so aggressive that the entire host population dies. The pathogens die at the same time, but that is not exactly a consolation to the hosts. We call this the phase transition to extinction (Figure 4). With increasing levels of global transportation, human civilization may be approaching such a critical threshold. Figure 4: The probability of survival makes a sharp transition (red line) from one to zero as we add more long range transportaion (horizontal axis). The right line (black) holds for different model parameters, so we need to study at what point the transition will take place for our world.

In the paper we wrote in 2006 about the dangers of global transportation for pathogen evolution and pandemics [8], we mentioned the risk from Ebola. Ebola is a horrendous disease that was present only in isolated villages in Africa. It was far away from the rest of the world only because of that isolation. Since Africa was developing, it was only a matter of time before it reached population centers and airports. While the model is about evolution, it is really about which pathogens will be found in a system that is highly connected, and Ebola can spread in a highly connected world. The traditional approach to public health uses historical evidence analyzed statistically to assess the potential impacts of a disease. As a result, many were surprised by the spread of Ebola through West Africa in 2014. As the connectivity of the world increases, past experience is not a good guide to future events. A key point about the phase transition to extinction is its suddenness. Even a system that seems stable, can be destabilized by a few more long-range connections, and connectivity is continuing to increase. So how close are we to the tipping point? We don’t know but it would be good to find out before it happens. While Ebola ravaged three countries in West Africa, it only resulted in a handful of cases outside that region. One possible reason is that many of the airlines that fly to west Africa stopped or reduced flights during the epidemic [9]. In the absence of a clear connection, public health authorities who downplayed the dangers of the epidemic spreading to the West might seem to be vindicated. As with the choice of airlines to stop flying to west Africa, our analysis didn’t take into consideration how people respond to epidemics. It does tell us what the outcome will be unless we respond fast enough and well enough to stop the spread of future diseases, which may not be the same as the ones we saw in the past. As the world becomes more connected, the dangers increase. Are people in western countries safe because of higher quality health systems? Countries like the U.S. have highly skewed networks of social interactions with some very highly connected individuals that can be “superspreaders.” The chances of such an individual becoming infected may be low but events like a mass outbreak pose a much greater risk if they do happen. If a sick food service worker in an airport infects 100 passengers, or a contagion event happens in mass transportation, an outbreak could very well prove unstoppable. Watch this mock video of a pathogen spreading globally through land and air transportation. Long range transportation will continue to pose a threat of pandemic if its impacts cannot be contained.

2023 SDI Affirmative
MSDI – Medicare for All Affirmative › 1AC --- Health Advantage

Disease spread is existential---best studies prove.

Kim ’21 [Kiseong, Sunyong Yoo, Sangyeon Lee, Doheon Lee, and Kwang-Hyung Lee; March 26; Department of Bio and Brain Engineering, KAIST; Research and Development Center at BioBrain Inc.; Department of ICT Convergence System Engineering, Chonnam National University; Bio-Synergy Research Center; Moon Soul Graduate School of Future Strategy; Applied Sciences, “Network Analysis to Identify the Risk of Epidemic Spreading,” vol. 11]

Several epidemics, such as the Black Death and the Spanish flu, have threatened human life throughout history; however, it is unclear if humans will remain safe from the sudden and fast spread of epidemic diseases. Moreover, the transmission characteristics of epidemics remain undiscovered. In this study, we present the results of an epidemic simulation experiment revealing the relationship between epidemic parameters and pandemic risk. To analyze the time-dependent risk and impact of epidemics, we considered two parameters for infectious diseases: the recovery time from infection and the transmission rate of the disease. Based on the epidemic simulation, we identified two important aspects of human safety with regard to the threat of a pandemic. First, humans should be safe if the fatality rate is below 100%. Second, even when the fatality rate is 100%, humans would be safe if the average degree of human social networks is below a threshold value. Nevertheless, certain diseases can potentially infect all nodes in the human social networks, and these diseases cause a pandemic when the average degree is larger than the threshold value. These results indicated that certain infectious diseases lead to human extinction and can be prevented by minimizing human contact.

1. Introduction

2023 SDI Affirmative
MSDI – Medicare for All Affirmative › 1AC --- Health Advantage

The present system is destroying the quality of medical care – over 60,000 preventable deaths each year. We further lack preventative medicine and adequate disease control. We could save over $650 billion a year and improve public health with Medicare for All.

Scott Deshefy, 5.20.2023 Healthcare, Save for Single-Payer Medicare and Medicaid, is Linked More by Financial Enrichment Than Humane Prolonging of Lives https://ctexaminer.com/2023/05/20/healthcare-save-for-single-payer-medicare-and-medicaid-is-linked-more-by-financial-enrichment-than-humane-prolonging-of-lives/

In the United States we spend twice as much per capita on healthcare as do other countries. That’s an average of $12,530 per person per year, totaling $4 trillion or roughly 20% of our GDP. Yet despite these cost disparities, America ranks near the bottom among major industrialized nations in medical outcomes, including longevity, childbirth mortality, equity, and fullness of coverage. America’s private healthcare, to put it bluntly, is a grossly inefficient money pit. That shouldn’t surprise anyone considering healthcare in the U.S., save for single-payer Medicare and Medicaid, is a disjointed collection of thousands of competing providers linked more by financial enrichment than humane prolonging of lives. In his latest book It’s OK to Be Angry About Capitalism, Senator Bernie Sanders, our sole visionary in elected office today, aptly describes America’s current for-profit healthcare system as “working exactly the way it was designed…for the people who own it.” Healthcare industry profits, soaring over $100 billion in 2021, attest to the need for complete overhaul to repair flaws and make it more serviceable to the rest of us. Until then, it will remain inaccessible to many in need of medical attention because the current system, dominated by private insurers and equally greedy pharmaceutical companies, is much too expensive, accounting for half of all U.S. personal bankruptcies (about 500,000 each year). More importantly, $60 billion in profits raked-in by the six largest health insurance companies in 2021 coincided with 85 million Americans either uninsured or underinsured that year. Another consequence of our misplaced priorities is that inadequate medical coverage contributes to an estimated 60,000 preventable deaths each year. Not only do patients and untreated suffer, but physicians are burdened by bureaucracy as well. Because a third of healthcare costs are spent on administration, physician costs for interactions with myriad insurers average about $80,000 per year. Maintaining a status quo which guarantees unconscionable wealth for insurance and drug companies (and aspiring billionaires controlling them) denies universal provision of medical service as a human right. That failure makes us the only major country not to guarantee healthcare for everyone. It also focuses medical attention, physiologically and psychologically, on retroactive treatment of illnesses much more than preventive medicine, proactive disease control and societal wellbeing as a whole. Countries with single-payer healthcare generally have populations which are healthier and happier than U.S. congeners. If we were to adopt a single-payer system here, fiscal analyses suggest Medicare-for-All, the most tenable option, could save our healthcare system $650 billion a year beginning in 2030 and provide much needed equity in medical coverage.

2023 SDI Affirmative
MSDI – Medicare for All Affirmative › 1AC --- Health Advantage

Medicare for All minimizes pandemic harms with rapid and efficient prevention, detection and mitigation efforts.

Galvani, et.al., 2020 Alison P. Galvani Alyssa S. Parpia Abhishek Pandey Charlotte Zimmer James G. Kahn Meagan C. Fitzpatrick Open Access Published:May 17, 2020 The imperative for universal healthcare to curtail the COVID-19 outbreak in the USA DOI:https://doi.org/10.1016/j.eclinm.2020.100380

Outbreak mitigation relies on prompt diagnosis and case-isolation, in which mild cases are quarantined at home and more severe cases are hospitalized. These measures must be implemented rapidly in order to be effective. However, for the millions of people who are either uninsured or underinsured, concern about the medical expenses that could be incurred delays diagnosis and treatment. While the Families First Coronavirus Response Act recently approved by Congress stipulates that COVID-19 diagnostic testing is nominally free for everyone, treatment is not covered. Those who are hospitalized may face major medical expenses. For instance, the cost of 12 days in the ICU on ventilation would likely exceed US $80,000 [ , ], even without considering the additional hospital care before and after ICU admission. In addition to the burden on the uninsured, the under-insured are obligated to pay substantial out-of-pocket sums, including thousands of dollars in deductibles and copays. Although the Coronavirus Aid, Relief, and Economic Security Act has invested $100 billion into the Public Health and Social Service Emergency Fund for healthcare providers, less than one third of this sum can be used to fund the treatment of uninsured COVID-19 patients. Compounding the crisis, legal action being pursued by the current Administration is jeopardizing the Affordable Care Act, which would lead to the loss of health insurance for as many as 30 million people [ ]. The COVID-19 pandemic also underscores the precariousness of a system in which insurance is linked to employment. Initial unemployment claims rose from 282,000 for the week ending March 14 to 6.6 million, 5.2 million and 4.4 million, for the weeks ending April 4, April 11, and April 18, respectively, compared with a previous record high of 695,000 from 1982 [ ]. Many of these newly unemployed individuals will lose their health insurance. Although they are permitted to purchase insurance on the federal exchange, switching networks disrupts continuity of care, which is particularly detrimental for those living with chronic health conditions. Furthermore, the majority of families are unable to afford health insurance upon becoming unemployed, given that more than half of American families live paycheck to paycheck [ ]. Racial and economic disparities in the US healthcare system are being magnified by the pandemic. Rates of adequate health insurance coverage are much lower among people of color [ ]. With less access to preventative healthcare, people of color are disproportionately affected by comorbidities, such as diabetes, obesity, asthma, and cardiovascular disease. These comorbidities exacerbate the severity of COVID-19 clinical outcomes, including death [ ], as does delay in seeking care due to concerns about medical bills. COVID-19 is widening socioeconomic fissures facing people of color as well. Since the start of the outbreak, Latino populations have reported much higher rates of job and wage loss than Americans at large [ ]. The solution to these challenges is the provision of comprehensive healthcare as a human right. Further, universal healthcare will be most cost-effectively achieved by a single-payer system, such as that proposed in the Medicare for All Act [ ]. Not only would Medicare-for-All save lives, it would resolve costly inefficiencies that currently make our healthcare system the most expensive in the world. Among the major sources of savings, a single-payer system would consolidate administrative costs, reduce overhead, empower pharmaceutical price negotiations, and truncate executive pay. A single-payer system is also incentivized to invest in cost-effective preventative services that can avert life-threatening clinical outcomes and expensive downstream treatment. Another advantage of Medicare-for-All during this pandemic would be its implementation of a standard billing and payment system, which would accelerate COVID-19 case reporting. Billing procedures currently vary across dozens of insurers, and for private insurance is proprietary. Within a consolidated system, patterns in the billing data can signal outbreak hotspots to public health surveillance officials. This consideration is not hypothetical – the single-payer system in Taiwan has facilitated exhaustive COVID-19 data collection and reporting [ ]. Universal healthcare is fundamental to the continued prosperity of our country in the wake of this and future infectious disease threats. Obstacles to prompt diagnosis and case isolation not only impact the individual, but pose a broader societal risk. A pandemic illustrates an omnipresent truth: that we are each only as safe as the most vulnerable member of our society. We urge investment now in the common good of healthcare security, by extending comprehensive insurance to all who currently lack it. Then, we should move swiftly to create a single-payer system, such as Medicare for All, which is the more efficient way to provide universal coverage [ ]. By eliminating financial obstacles to healthcare, we can pave the way for more efficient outbreak control, in both this pandemic and the next.

2023 SDI Affirmative
MSDI – Medicare for All Affirmative › 1AC --- Health Advantage

Future deadly pandemics are inevitable – universal health care is critical to preparing for and navigating these challenges.

Shafaati, et.al., 2023 Maryam Shafaati, Hitesh Chopra, Priyanka, Rekha Khandia, Om Prakash Choudhary, Alfonso Rodriguez Morales, The Next Pandemic Catastrophe: Can we Avert the Inevitable. March 10 2023 New Microbes New Infections https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9998279/

The world faced an unprecedented health crisis due to the spread of the coronavirus pandemic. Over 756 million confirmed cases and over 6.8 million fatalities had been reported globally as of February 18, 2023. While the pandemic has been devastating, it has also been a wake-up call to the world about the need for better preparedness and response to future health crises []. The ability to predict future pandemics using current scientific knowledge and the aid of specialists is one of the essential concerns in global health owing to pandemics being one of the primary forces driving the globalization of science and following those specialists are seeking a pathogen and a solution to control it. The why only some of the pathogens are mentioned as having an actual or potential pandemic should also be addressed simultaneously []. The history of pandemics has shown that humans and pathogens coevolved. Environmental changes also accelerate this process, meaning immunization is only part of the process. That is where the idea of “emerging and reemerging infectious diseases” begins. The majority of pandemics have been spread among species by spillover and zoonosis. For instance, the most recent COVID-19, mpox, poliovirus, and respiratory syncytial virus (RSV) outbreaks have all provided additional evidence. It is difficult to say whether or not we can stop or predict the next pandemic disaster. Because preparing for the future aims to increase awareness of the vulnerabilities existing in the present rather than to forecast what will happen in the future []. The increased migration of animals and animal products has also contributed to the threat of developing illnesses. Every year, new strains of avian influenza circulate among wild birds around the globe. In addition, intensive poultry farming techniques enhance the likelihood that domestic birds will be infected by wild birds, which might then be transmitted to poultry workers. Invasion of virgin forests for lumber and mining can expose humans to pandemic-prone diseases like Ebola. Other potential viruses that might spillover from the zoonotic reservoir and possibly be capable of person-to-person transmission are the Chapare Hemorrhagic Fever virus, Lassa virus, Crimean-Congo Hemorrhagic Fever virus, Rift Valley Fever virus, Alkhurma Hemorrhagic Fever virus, Kyasanur Forest Disease virus, and Omsk Hemorrhagic Fever virus []. Other sources include the amplification of diseases in healthcare settings at the onset of a pandemic where infection prevention and control measures are inadequate, the increased spread in dense, overpopulated cities, and the accidental release of high-risk pathogens due to inadequate biosecurity measures in laboratories researching these pathogens. Rising temperatures allow mosquitoes, ticks, and other disease-carrying insects to grow, adapt to changing seasons, and invade new territory, which increases the likelihood of a pandemic. For instance, flooding caused by harsh weather provides additional mosquito breeding grounds, increasing the probability of spreading dengue and other arboviral diseases. Melting permafrost can cause the discharge of diseases from animal corpses, such as the 2016 anthrax epidemic on the Yamal Peninsula in Siberia. Understanding how new viral agents emerge, behave, and use is one of the most accessible factors in predicting future epidemics that must be considered to create and implement efficient policy measures to reduce socioeconomic repercussions. It also is imperative to see whether the environmental factor or human invasion is responsible for some critical mutations in organisms that made them pathogenic, which otherwise were non-pathogenic. An example is Zika which was found to cause mild disease symptoms at the time of detection but later gained pathogenicity leading to microcephaly and Guillain-Barre syndrome, and subsequently gained 12 amino acids substitutions and displayed enhanced neurovirulence []. Governments rely mainly on prior epidemiological models in this situation. To navigate a challenging future, human society requires a stable vision. So, to reduce the emergence of future epidemics and other health emergencies, human society must be guided towards sustainable communities that respect wildlife, the environment, and their natural resources. Human curiosity leads him to discover new things, but his attitude may also be harmful. Global warming is breaking the ice sheets, permafrost, and glaciers that contain many viruses and other pathogens in the dormant stage. Genetic analysis of soil and lake sediments of Arctic freshwater lake Lake Hazenm revealed molecular signatures closer to existing viruses with risks of virus spillover. Breaking the permafrost layer just for adventure and curiosity and exposing the ice layer encompassing various dormant pathogens could be a recipe for disaster. Hence, in thinking about and preparing for future pandemics, Health organizations and governments should have documented programs for choosing to adopt, adapt, and improve their methods of operation in advance []. The key to averting the next pandemic catastrophe is to be prepared. That means strengthening public health systems and investing in research and development to create new treatments and vaccines. It also means increasing access to education and resources in vulnerable communities, so people can better understand and take preventive measures []. One approach to avoiding and controlling future pandemics could be developing a global One-Health program. The World Health Organization (WHO) has identified six critical areas for pandemic preparedness: risk assessment, surveillance, laboratory capacity, clinical management, public health interventions, and risk communication []. Existing plans in advance are required. This plan should include strategies for prevention, mitigation, and response. Prevention strategies should focus on risk assessment and risk reduction, while mitigation strategies should focus on creating protective measures and evacuation plans. Response strategies should focus on providing timely and effective aid to those affected by the disaster. Creating a communication plan and developing partnerships with local and international organizations can also help ensure a coordinated response []. Predictions and projections of weather and climate changes in the eco-epidemiological contexts favouring the spillover events might help understand future pandemics. The spillover risk can be minimized by reducing human encroachment on wildlife and interrupting animal-to-human transmission chains. Measures are needed to prevent endemics from becoming pandemic by effectively monitoring disease and real-time tracking through enhancing international collaboration to obtain better preparedness. Machine learning and artificial intelligence may help in developing a mechanistic and dynamics spatiotemporal disease spread model [], the status of infection in vaccine recipients [] and vaccine adverse effects through a natural language processing approach []. Risk assessment is an understanding of the possible risks caused by a virus or other infection. That includes monitoring the spread of the virus, tracking its mutations, and analyzing the risk factors associated with infection. Surveillance involves collecting and analyzing data to identify and monitor disease trends and inform public health interventions. It is essential to address the limitations and challenges of the existing infectious disease surveillance programs and warning systems to alert in case of pandemics. Blockchain technology, the pool of structurally and functionally different databases, may be used to trace infectious diseases for information management []. Blockchain technology rapidly detects infection data from individuals. Furthermore, it can ameliorate data processing to make it worthwhile for scientific research and applicable to government and political implications. Blockchain technology ensures data immutability, transparency, and traceability, which are essential during possible outbreaks. Using blockchain technology, patient movement, real-time data of affected areas, and implicated strategies to fight disease may be tracked. Potentially infected index cases may be monitored at each stage with reliability and accuracy in the form of blocks, where each block stores the outbreak update at a particular point, and a combination of blockchain with artificial intelligence and geographical information system will be more robust in surveillance programs . In addition, the technology will help track and determine the correct allocation and distribution of vaccines . Laboratory capacity is essential for diagnosing and testing for the virus, as well as for developing treatments and vaccines. Clinical management includes giving affected people health care, medicines, and vaccinations. Public health interventions, such as contact tracing, quarantining, and social seclusion, are actions used to stop the virus from spreading. Risk communication involves educating the public about the virus, its risks, and how to stay safe. Investing in international cooperation, public health systems, and research and development are essential for pandemic preparedness and response . It is critical to improving vulnerable groups' access to resources and education. That includes giving access to medical care and treatment, information about the infection, and how to protect oneself. In addition, it's critical to offer financial assistance to people affected by the pandemic, such as those who have lost their jobs or are ill and unable to work . PANDEM-2 is one of the leading programs. PANDEM-2 aims to discover, map, and integrate data from numerous sources into a cohesive pandemic-management database and provide a comprehensive dashboard for pandemic preparedness training and response. The dashboard gathers sources of information on the social, economic, and health-related effects of a pandemic. The PANDEM-2 project will include the lessons learned from the current COVID-19 pandemic and implement worldwide best practices in modelling, simulations, pandemic messaging, contact tracking, and training . PANDEM-2 will assist public health agency pandemic managers, first responders, laboratory workers, and hospital administrators. Advances in visual and data analytics will aid pandemic managers in making crucial decisions, thereby decreasing the impact of future pandemics on EU residents. State and federal leaders must demonstrate national leadership and unity to combat the next health hazard. Despite its evident threat to world health, economics, and security, the COVID-19 pandemic has, with a few exceptions, been characterized by excessive rhetoric and insufficient action. The worldwide COVID-19 meetings have resulted in commendable financial promises, and leaders have addressed WHO conferences, but action has not been sustained . Preparedness in the vaccine development program should be state of the art, where a vaccine can be prepared immediately after diagnosing the infecting agent. An mRNA-based vaccine may be readily developed against virtually almost all viral pathogens with information of only genomic sequence in hand. Robust animal models are required to identify the vaccine efficacy reliably. The number of biocontainment labs should be increased to receive samples for diagnosis from nearby outbreak sites immediately. An adequate number of such facilities will reduce the workload and associated human errors in existing labs. Horizontal and vertical transfer of pathogens with the involvement of new potential hosts is also essential to determine. Apart from biosafety, biosecurity is also an important measure to be taken when encountering new pathogens having the potential to reason a pandemic. It is the shared responsibility of scientists and the government to ensure the swift implementation of related laws to minimize the possibilities of laboratory escape or misuse of these pathogens []. Therefore, a global council of leaders must identify gaps in readiness and reaction, mobilize funds, keep public and private actors responsible, and give leadership at the first sign of a threat. This council should be constituted by a political statement made by the General Assembly of the United Nations. In conclusion, being prepared is the key to preventing the next pandemic disaster. Public health services must be strengthened, and money must be spent on research and development to produce new medications and vaccinations. For people to understand prevention better and take preventive action, expanding access to education and resources in vulnerable communities also entails increasing access to education and resources. Additionally, it is crucial to invest in international cooperation to help countries at risk of outbreaks and provide economic support to those affected by the pandemic. Unfortunately, past crises have demonstrated that governments and donors typically shift their focus to more critical issues after an outbreak is under control. This “panic-then-forget” loop has hampered the global development of efficient health emergency preparedness. This vicious loop must be broken once and for all.

2023 SDI Negative
MSDI Case Neg vs Medicare for All › Innovation DA › Innovation Turns Economy

Innovation guarantees jobs and economic leadership for the U.S.

TechNet is the national, bipartisan network of CEOs that promotes the growth of technology industries and the economy by building long-term relationships between technology leaders and policymakers and by advocating a targeted policy agenda, “America’s Technology Leaders Assert Innovation Key to Nation’s Recovery and Global Competitiveness,” 2011, , accessed 9-10-2012.

Nearly 60 executives from TechNet, the bipartisan policy and political network of CEOs that promotes the growth of the innovation economy, assemble in Washington, D.C. this week for the organization’s annual CEO fly-in to meet with America’s policy leaders and advocate for innovative policy solutions to create jobs and grow the U.S. economy. The TechNet executives are meeting with senior Obama Administration officials and an array of bipartisan Congressional leaders to advocate for a robust innovation policy agenda comprised of three critical areas: improving the nation’s education system and human capital support; fostering a globally competitive business climate including comprehensive tax reform; and driving investment for clean technology and 21st century energy solutions. “To win the future, America must invest in innovation and the future discoveries that will create good paying jobs for more of our people,” said Rey Ramsey, President and CEO of TechNet. “To reach this goal, we must make the smart policy choices on R&D, education, comprehensive tax reform, high skilled immigration and protecting intellectual property. These are fundamental kitchen table issues that will help grow jobs here in America. Our message to our policy leaders is that we will work with you to ensure that America remains the world’s center of innovation and economic growth.”

2023 SDI Negative
MSDI Case Neg vs Medicare for All › Innovation DA › Innovation Turns Economy

Historical analysis establishes innovation as a key marker of economic growth

Kelly, et.al., 2019 Bryan Kelly Dimitris Papanikolaou Amit Seru Matt Taddy 2019 How Much Does Innovation Drive Economic Growth? https://insight.kellogg.northwestern.edu/article/measuring-innovation-patents-productivity

Since the 1800s, productivity—the amount of value a company creates per dollar of investment or hour of worker labor—has increased in the U.S. Indeed, this long-term trend has been largely responsible for economic growth nationwide over the last two centuries, allowing incomes to rise even as the workweek has grown shorter and production less capital-intensive. But it is not clear why productivity grew throughout this period—let alone why it grew faster in some years than others, or why different industries have experienced particular ups and downs. That’s a puzzle that Kellogg professor of finance Dimitris Papanikolaou has thought a lot about. “What’s driving productivity differences over time and across firms and sectors?” Papanikolaou asks. “People say, ‘Oh, it’s innovation, technological change.’ But we don’t have great measures of those things. That’s what motivated our research.” With collaborators Bryan Kelly of Yale, Amit Seru of Stanford, and Matt Taddy of Amazon, Papanikolaou drew on an enormous database of U.S. patents to develop a novel measure of innovation. The researchers measured the quality of each patent by comparing how similar its text was to earlier and later patents—the idea being that highly innovative patents should be unlike anything that came before, but influential enough that later inventors would adapt and expand on them. By counting how many exceptionally innovative patents are filed in a particular year, they could estimate how much breakthrough innovation happened that year. The researchers found that changes in the level of breakthrough innovations were associated with changing productivity levels across time periods, industries, and firms. Moreover, spikes in patent quality successfully predicted watershed inventions as well as individual firm profits, suggesting that innovation might indeed be key to understanding the last two centuries of economic growth. “We provide robust evidence that technological progress is correlated with productivity,” Papanikolaou says, “by creating the first direct measure of technological progress that is comparable across time and space.” How to Measure Innovation Innovative new technologies can improve productivity by making work faster, cheaper, and easier. But innovation has typically been a difficult thing for researchers to measure, according to Papanikolaou. Most studies of innovation have relied on patents. “Not all innovations are patented, but patents by definition are related to invention,” he says. “That seemed like a useful starting point.”

2023 SDI Negative
MSDI Case Neg vs Medicare for All › Innovation DA › Innovation Turns Economy

Innovation is necessary for economic growth

European Central Bank 27 June 2017 How does innovation lead to growth? https://www.ecb.europa.eu/ecb/educational/explainers/tell-me-more/html/growth.en.html#:~:text=One%20of%20the%20major%20benefits,other%20words%2C%20the%20economy%20grows.

One of the major benefits of innovation is its contribution to economic growth. Simply put, innovation can lead to higher productivity, meaning that the same input generates a greater output. As productivity rises, more goods and services are produced – in other words, the economy grows. New ideas and technologies are developed and applied, generating greater output with the same input. More goods and services are produced, stimulating wages and business profitability. nnovation and productivity growth bring vast benefits for consumers and businesses. As productivity rises, the wages of workers increase. They have more money in their pockets, and so can buy more goods and services. At the same time, businesses become more profitable, which enables them to invest and hire more employees.

2023 SDI Negative
MSDI Case Neg vs Medicare for All › Innovation DA › Innovation Turns Economy

Innovation is a prerequisite to economic growth

US Chamber Foundation, 2013 “Innovation drives economic growth“ https://www.uschamberfoundation.org/enterprisingstates/assets/files/Executive-Summary-OL.pdf

Innovation drives economic growth. This is one of the most consistent findings in macroeconomics, and it’s been true for centuries. America’s genius for innovation and entrepreneurial drive is well known—with our openness and enthusiasm for practical innovation from the steam engine to the search engine—to be the primary reason for America’s economic preeminence. Economists have calculated that approximately 50% of U.S. annual GDP growth is attributed to increases in innovation.

2023 SDI Negative
MSDI Case Neg vs Medicare for All › Innovation DA › Innovation Turns Economy

Innovation is an essential driver of economic growth

Sarangi, et.al., First published online December 9, 2021 Ajoy K Sarangi, Rudra P. Pradhan rudrap@vgsom.iitkgp.ernet.in, […], and Hiranmoy Roy+2 View all authors and affiliations How Does Innovation Affect Economic Growth? Evidence from G20 Countries Volume 70, Issue 1 https://journals.sagepub.com/doi/full/10.1177/00194662211063562

Innovation is an essential driver of economic progress that benefits consumers, businesses and the economy as a whole. How does it play that role, how does it contribute to economic growth and what can be done to promote it? () Both economists and policymakers have primed significant progress in economic growth modelling and recognising the mechanisms of economic growth over the last couple of decades. It appears that they have extended a consent on the opinion that long-term economic growth is primarily merchandise of innovation (see , ). The importance of innovation in economic development has received much attention in the academic literature, particularly since the seminal work of . There are at least two ways we can justify the contribution of innovation to economic growth: (a) innovation landfills to the discovery of new technology, systems and processes that improve productivity and efficiency within the economy and (b) innovation is very vital for the development of new value-added products and services, backing to new income generation channels (see ; ; ; ; ; ; ; ). Innovation is very critical to the global economy, individual economies and regions within nations as the world seeks to emerge from the special effects of the global economic crisis, such as the global financial crisis between mid-2007 and early-2009 and the ongoing Coronavirus disease pandemic (see ; ; ; Sivak et al., 2011). At the policy level, innovation helps to drive economic growth and can address many socio-economic challenges, namely, poverty, education, health and infrastructure. Similarly, several growth-enhancing innovations can also address various socio-economic challenges (see OECD, 2012). All around, a strong consensus has emerged in the last few decades that a well-developed innovative system has a significant impact on economic growth. Obviously, the issue is ‘what drives innovation’; and understanding the determinants of innovation is very imperative because innovations institute companies’ competitive advantages () and are essential drivers of economic growth (). The theoretical linkage between innovation and economic growth can be well-restored in .